Pain Management Devices Market

Global Pain Management Devices Market Size

The global pain management devices market, valued at USD 8.39 billion in 2025, is projected to reach USD 8.84 billion in 2026 and USD 13.32 billion by 2035, with a 9.6% CAGR during the forecast period 2026 to 2035.

To learn more about this report, request a free sample copy

Researchers describe pain as an unpleasant sensory experience that is primarily associated with any acute / chronic physical injury and can accentuate with various psychological, biological, and social factors. The prevalence of pain is substantial, impacting a significant number of individuals globally. Given the widespread prevalence of pain across various geographies, effective pain management solutions are crucial to improving patient outcomes and enhancing their quality of life.

Pain management typically involves the deployment of devices that can alleviate the suffering of individuals with musculoskeletal, spinal and neuropathic pain. Amongst the treatment options available, pharmacological interventions serve as a first-line treatment option for managing and treating both acute and chronic pain. Regardless of their effectiveness in relieving the pain, these drugs are associated with various side-effects, including induction of a euphoric state (that may hamper the mundane activities) and drug addiction (that may lead to death).

The opioid crisis / epidemic (as a result of overuse / misuse / abuse) has prompted industry stakeholders to develop a vast array of patient-centric devices, including neurostimulation devices, infusion pumps and radiofrequency ablation devices in order to manage pain effectively. These devices serve as second line of treatment option for decreasing pain threshold, and offer various advantages, including minimal / no drug interaction, targeted therapy, reduced dependency on medications and minimal adverse effects.

Pain Management Devices Market: Report Attributes

Key Report Attributes	Details
Historical Trend	Since 2020
Forecast Period	Till 2035
Market Size 2026	$ 8.84 Billion
Market Size 2035	$ 13.32 Billion
CAGR (Till 2035)	9.6%

The pain management devices market analysis also features the likely distribution of the current and forecasted opportunity within the pain management devices domain across various segments, such as type of device, type of neurostimulation device, application area, mode of purchase, end user, geographical regions and leading players.

We have created three market forecast scenarios, conservative, base and optimistic, to account for future uncertainties in key parameters and enhance the robustness of our model. These scenarios represent different tracks of the industry's evolution.

The rising prevalence of chronic pain, ageing population, and integration of technological advancements (including artificial intelligence) in the development of novel devices for effective management of pain are likely to drive the market during the forecast period.

Recent Developments in Pain Management Devices Market

Several recent developments in the field of pain management devices have occurred, and we outline some of these below. These developments, even if they arose after our market report’s release, support the overall pain management devices market trends detailed in our analysis.

• In February 2026, CURAPOD (Healthcare Startup) raised INR 20 crore (USD 2.2 million) in a pre-series A funding round to scale wearable pain management technology.
• In October 2025, Boston Scientific announced the acquisition of Nalu Medical for USD 533 million in upfront cash, enhancing its neuromodulation portfolio.
• In September 2025, AtriCure launched cryoXT™ device, designed for post-operative pain management following amputation surgeries, providing targeted cryo nerve therapy to reduce acute pain in surgical patients across US hospitals.
• In August 2025, FDA approved the One™ Radio Ablation System for the treatment of trigeminal neuralgia via radiofrequency ablation.
• In July 2025, Neuros Medical raised $56 million in Series D funding to accelerate the US commercial launch of its Altius® system, a non-opioid device delivering on-demand treatment for chronic post-amputation pain in patients.
• In July 2025, SetPoint Medical received FDA approval for its SetPoint System, the first implantable neuroimmune modulation device for rheumatoid arthritis patients inadequately managed by existing therapies, targeting inflammation-related chronic pain.

Pain Management Devices Market Segmentation Insights

The market research report presents an in-depth analysis of the various pain management device manufacturers, across different segments, as defined in the table below:

Pain Management Devices Market: Market Segmentations

Market Segmentations	Details
Type of Device	Neurostimulation Devices Infusion Pumps Ablation Devices Virtual Reality Devices Other Devices
Type of Neurostimulation Device	Spinal Cord Stimulator Peripheral Nerve Stimulators Transcutaneous Electrical Nerve Stimulators Deep Brain Stimulators Other Stimulators
Application Area	Neuropathic Pain Musculoskeletal Pain Cancer Pain Trauma and Surgical Pain Facial Pain and Migraine Other Application Areas
Mode of Purchase	Prescription Over-the-Counter
End User	Hospitals and Clinics Physiotherapy Centers Other End Users
Geographical Regions	North America Europe Asia-Pacific Middle East and North Africa Latin America
Market in North America	US Canada
Market in Europe	France Germany Italy Spain UK Rest of the Europe
Market in Asia-Pacific	Australia China India Indonesia Japan South Korea Rest of Asia-Pacific
Market in Middle East and North Africa	Israel Saudi Arabia UAE
Market in Latin America	Brazil Mexico Rest of Latin America

As the industry progresses towards addressing the concerns associated with conventional pain management devices and conducting more R&D towards the development of highly efficient, safe, cost-effective and minimally invasive pain management devices that can support management of different pain indications, the adoption of such devices will gradually rise. As the potential of these devices unfolds, their rate of adoption will be faster in the foreseen future.

Pain Management Devices Market Share Insights

Market Share by Type of Device: Neurostimulation Devices Segment Holds the Largest Share

• The market for pain management devices is categorized into different types of devices, such as neurostimulation devices, infusion pumps, ablation devices, virtual reality devices and other devices. The neurostimulation devices segment led the market, capturing the largest revenue share (more than 60%) in 2026. This is due to their effectiveness in pain management and the ability to be customized as per individualistic needs, while reducing the medication requirements.
• The virtual reality devices segment is likely to show a relatively higher growth rate of 5.4%, during the forecast period. This is due to the fact that virtual reality devices divert attention from pain through rich sensory experiences, which further provide mental and physical relaxation, lowers blood pressure and reduces stress.

Market Share by Type of Neurostimulation Device: Spinal Cord Stimulator Segment Dominates the Market

• The spinal cord stimulator segment led the market, capturing the largest revenue share (close to 70%). Further, this segment is likely to show a higher annual growth rate of ~5.6%, during the forecast period.
• This is likely due to the increased prevalence of medically unresponsive conditions such as neuropathic and musculoskeletal pain. The advancements in the technology of spinal cord simulators (for making them minimally invasive and more effective) have led to their widespread adoption in the treatment of such unresponsive conditions, contributing significantly to their market growth.

Market Share by Application Area: Neuropathic Pain Segment Hold the Largest Share

• The pain management devices market forecast is categorized into different application areas, such as neuropathic pain, musculoskeletal pain, cancer pain, trauma and surgical pain, facial pain and migraine and other application areas. The neuropathic pain segment led the market, capturing the largest revenue share (close to 35%) in 2026. This is likely due to the growing prevalence and rising expenditure for the management of neuropathic pain.
• The cancer pain segment is likely to show a higher annual growth rate of ~6%, during the forecast period. This is due to the growing global incidence of oncological disorders, which has necessitated the development of effective devices to manage cancer pain.

Market Share by Mode of Purchase : Prescription Products Segment Dominates Pain Management Devices Market

• The market is segmented into different modes of purchase, such as prescription and over-the-counter. The prescription products segment led the market, capturing the largest revenue share (more than 95%) in 2026. This is likely due to the fact that invasive pain management devices (prescribed by healthcare professionals) are the most widely used devices across the world.
• In the coming years, as regulatory authorities approve a higher number of non-invasive neurostimulation devices for pain management, we expect the market for over-the-counter devices to experience a higher growth rate (~6%) during the forecast period.

Market Share by End User : Hospitals and Clinics Segment Dominates Pain Management Devices Market

• The hospitals and clinics segment led the market, capturing the largest revenue share (more than 75%) in 2026. This is likely due to the fact that hospitals and clinics offer comprehensive pain management programs and access to advanced medical technologies.
• The physiotherapy centers segment is likely to show a higher annual growth rate of ~5.5%, during the forecast period. Various factors, such as increasing awareness of non-invasive therapies and increasing availability of specialized physiotherapy centers (especially in the US and European countries) are likely to drive the growth of segment.

Market Share by Geographical Regions : Asia-Pacific to Propel in the Pain Management Devices Sector in the Coming Years

• This segment highlights the distribution of market across various geographical regions, including North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America. According to our projections, North America is likely to capture the majority (more than 50%) of the pain management devices market share in 2026, and this trend is unlikely to change in the future.
• It is worth highlighting that the market in Asia-Pacific is likely to grow at a relatively higher CAGR (6.5%), during the forecast period. This is a result of the growing geriatric population, rising incidence of chronic diseases in this region, coupled with the availability of advanced, novel pain management devices.

Pain Management Devices Market: Report Deliverables

Key Report Attributes	Details
Excel Data Packs (Complimentary)	Market Landscape Company Competitiveness Analysis Publication Analysis Market Forecast and Opportunity Analysis
Pain Management Device Manufacturers Companies Profiled	Abbott AppliedVR AtriCure Avanos Medical Becton, Dickinson and Company BioElectronics Hexainnoheal Litemed Medtronic Micrel Medical Devices Nalu Medical Nevro Smileyscope Stryker ZetrOZ Systems Zynex Medical (Full list of 30+ companies captured is available in the report)
PowerPoint Presentation (Complimentary)	Available
Customization Scope	15% Free Customization

Pain Management Devices Market Major Takeaways

The “Pain Management Devices Market: Industry Trends and Global Forecasts, till 2035” market report features an extensive study of the current market landscape, company competitiveness analysis, publication analysis and market size and future opportunities within the pain management devices industry, during the forecast period.

Competitive Landscape of Pain Management Device Developers

The current market landscape features over 30 leading players across different regions which claim to offer various pain management devices. It is interesting to note that to meet the growing demand for these devices, the companies engaged have undertaken several initiatives, such as making strategic acquisitions and expanding their existing capabilities / product portfolios.

Market Size Analysis: What is the Opportunity for the Pain Management Devices Market?

The global pain management devices market size is likely to be worth $ 8.84 billion in 2026 and will reach $ 13.32 billion by 2035. It is worth highlighting that currently, the market is dominated by revenues generated from neurostimulation devices and this trend (in terms of market share) is likely to remain the same during the forecast period.

Various factors, including increasing prevalence of chronic pain conditions, such as arthritis, cancer, and neuropathic pain and technological advancements in pain relief solutions are driving the pain management devices market. Moreover, rising healthcare expenditure, favorable regulatory approvals and reimbursement frameworks collectively contribute to the growth of the pain management devices industry.

Regional Analysis: Which Region Holds the Largest Share of the Pain Management Devices Market?

North America is Leading the Market

North American companies will likely dominate the global pain management devices market in 2035. Presently, North America captures the majority (50%) of the market share, and this trend is unlikely to change in the future. This can be due to the rising prevalence of chronic pain (particularly neuropathic pain) in the US. Further, favorable reimbursement policies in this region have created a conducive environment for pain management devices market growth.

Asia-Pacific: An Emerging Growth Spot

The market in Asia-Pacific is likely to grow at a relatively high CAGR, during the forecast period till 2035. This can be likely due to the rising geriatric population and improving healthcare infrastructure in this region, for the effective management of pain.

What are the Key Drivers of Pain Management Devices Market?

Growing geriatric population, lifestyle habits and the rising incidence of chronic diseases have led to the growing prevalence of chronic pain conditions, such as arthritis and diabetic neuropathy, which demand effective and long-term treatment solutions, such as non-invasive pain management devices for neuropathy . This has spurred the need for pain management devices.

Ongoing technological advancements in pain relief solutions have led to the enhancement of treatment efficacy and patient comfort. Therapists use virtual reality therapy, which immerses individuals in computer-generated worlds, to divert attention from pain through rich sensory experiences and to tailor it to specific health conditions, such as chronic pain and post-surgery recovery, without the need for invasive procedures or medication.

Pain Management Devices Market Trends

Technological Advancements to Fuel Innovation and Drive Efficiency

Artificial Intelligence and machine learning have further advanced pain management systems, enabling personalized, adaptive, and effective treatment options. In addition to conventional pain management devices, practitioners are using several non-pharmacological interventions (virtual reality and augmented reality) to mimic the exact neurobiological mechanisms and reduce the pain threshold. These pain-attenuating effects (especially through virtual reality) have the ability to revolutionize the pain management landscape by providing more effective and long-lasting solutions.

As awareness of the risks associated with opioid use grows, more people will likely adopt these advanced pain management devices, which will complement the pharmacological agents. The pace at which industry stakeholders are undertaking initiatives in this industry suggest that pain management devices hold immense promise as powerful tools for alleviating pain and improving the lives of patients with chronic pain.

Pain Management Devices Market Report Coverage

The market report presents an in-depth analysis, highlighting the capabilities of various stakeholders in the pain management devices industry, across different geographies. Amongst other elements, the market report includes:

• An Infographic Executive Summary
• Market Landscape of Pain Management Device Manufacturers
• Market Landscape
• Company Competitiveness Analysis
• Company Profiles
• Publication Analysis
• Porter’s Five Forces Analysis
• Market Forecast and Opportunity Analysis

From the Author’s Desk

Author’s View on Pain Management Devices Market

As industry progresses towards addressing the concerns of conventional pain management devices and conducting more R&D towards the development of safe and minimally invasive devices that can support management of different pain-related indications, the adoption of pain management devices will gradually rise. As the potential of these devices unfolds, the domain will likely witness an increase in the adoption rate of such devices for pain management.

About Author’s

Lead Author: Usama Bin Firoz

Lead Reviewer: Parneet Kaur

Chief Editor: Prachi Bhalla

Glossary

• Pain: Pain is a multisensory experience that encompasses various underlying causes, including neurophysiological, biochemical, psychological, cognitive and environmental factors.
• Acute Pain: It is a physiologic response to an adverse chemical, thermal, or mechanical stimulus, often resulting from surgery, trauma, or acute illness.
• Chronic Pain: Pain lasting for over six months or persisting beyond the course of an acute disease or post tissue healing.
• Neurostimulation: Neurostimulation is an electromagnetic approach to neuromodulation, which involves targeted activation or modulation of neuronal activity through the use of electrical or magnetic stimulation.
• Ablation Devices: These devices are minimally invasive medical device that utilize various forms of energy, such as radiofrequency and cryogenic energy, to destroy or remove the targeted tissue / nerves.
• Analgesic Infusion Pumps: These are medical devices designed to deliver pain-relieving medications directly into the body, typically through intravenous, subcutaneous or epidural routes.

Frequently Asked Questions

Question 1: What are pain management devices?

Answer: Invasive or non-invasive devices designed to alleviate or manage both acute and chronic pain. Healthcare providers can use these devices in home settings / clinical settings to provide personalized care to the patients and have shown promising results to improve patients' quality of life.

Question 2: How big is the pain management devices market?

Answer: The global pain management devices market size is likely to reach USD 13.32 billion by 2035.

Question 3: Which country is expected to hold the majority share of the pain management devices market in the year 2035?

Answer: The US is likely to hold the majority share (40%) of the market in 2035.

Question 4: What is the estimated market growth for pain management devices market?

Answer: The pain management devices market forecast is estimated to grow at an annualized CAGR of 9.6%, during the forecast period.

Question 5: Who are the key pain management device companies?

Answer: Abbott, AppliedVR, AtriCure, Avanos Medical, Becton Dickinson and Company, BioElectronics, Hexainnoheal, Litemed, Medtronic, Micrel Medical Devices, Nalu Medical, Nevro, Smileyscope, Stryker, ZetrOZ Systems and Zynex Medical.

Question 6: What are different types of pain management devices?

Answer: The various types of pain management devices include spinal cord stimulators, peripheral nerve neurostimulators, transcutaneous electrical nerve stimulators, deep brain stimulators, infusion pumps, ablation devices and virtual reality devices.

Question 7: What is the demand for pain management?

Answer: The demand for pain management is growing due to increasing geriatric population, rising prevalence of chronic pain and the increased adoption of these devices.